NCT03387462View on ClinicalTrials.gov

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

August 30, 2018

Study Completion Date

August 30, 2018

Conditions
Adherence, MedicationRisk BehaviorPre-Exposure ProphylaxisHIV Prevention
Interventions
DRUG

Emtricitabine / Tenofovir Disoproxil Oral Tablet

Open label daily emtricitabine/tenofovir disoproxil oral tablet

OTHER

DOT Diary mobile app

DOT Diary mobile application for tracking medication adherence and sexual activities.

Trial Locations (2)

30322

Emory University, School of Public Health, Atlanta

94102

Bridge HIV, San Francisco Department of Public Health, San Francisco

Sponsors

Collaborators (1)

AiCure
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

San Francisco Department of Public Health

OTHER_GOV

collaborator

Emory University

OTHER

collaborator

AiCure

INDUSTRY

lead

Public Health Foundation Enterprises, Inc.

OTHER

NCT03387462 - DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence | Biotech Hunter | Biotech Hunter